Search bioRxiv⌕ Search

Biology subjects

Tasker, C.

Publications and source records attributed to Tasker, C..

2 recordsLinked to original sources

Multiomics profiling of APECED peripheral blood highlights compositional increases in alternatively activated B cell subsets

APECED (Autoimmune PolyEndocrinopathy Candidiasis Ectodermal Dystrophy) is a rare syndrome of multi-organ autoimmunity driven by the presence of self-reactive T cells and autoantibodies caused by mutations in the gene Autoimmune regulator (AIRE). Compared to the well-defined role of AIRE in establishing and maintaining T cell central tolerance, less is known about how AIRE deficiency impacts B cell phenotypes that may contribute to a breakdown in peripheral B cell tolerance. Here we analyzed serum and peripheral blood cells from APECED patients and healthy donors using autoantibody profiling, proteomics, flow cytometry, scRNAseq based subset analysis, BCRseq, and autoantigen binding assays finding significant changes to the APECED B cell compartment. We show that while Naive and Transitional B cells are reduced, alternatively activated B cell subsets are expanded in APECED patients including IgM CD27+ and class switched Atypical B cells which exhibit BCR chain features prone to autoreactivity. Antibodies derived from either APECED or Healthy class switched atypical B cells bind autoantigens at significantly higher rates than control IgG B cells. Serum autoantibodies and proteomics highlight APECED common and patient variable changes. These results together show that APECED causes a compositional shift towards subsets that may promote broken B cell tolerance and autoimmunity.

immunology↗

Interferon epsilon restricts Zika virus infection in the female reproductive tract

Interferon {varepsilon} (IFN{varepsilon}) is a unique type I IFN that has been implicated in host defense against sexually transmitted infections (STIs). Zika virus (ZIKV), an emerging pathogen, can infect the female reproductive tract (FRT) and cause devastating diseases, particularly in pregnant women. How IFN{varepsilon} contributes to protection against ZIKV infection in vivo is unknown. Here, we show that IFN{varepsilon} plays a critical role in host protection against vaginal ZIKV infection in mice. We found that IFN{varepsilon} was expressed not only by epithelial cells in the FRT, but also by certain immune and other cells at baseline or after exposure to viruses or specific TLR agonists. IFN{varepsilon}-deficient mice exhibited abnormalities in the epithelial border and underlying tissue in the cervicovaginal tract, and these defects were associated with increased susceptibility to vaginal, but not subcutaneous ZIKV infection. IFN{varepsilon}-deficiency resulted in an increase in magnitude, duration, and depth of ZIKV infection in the FRT. Critically, intravaginal administration of recombinant IFN{varepsilon} protected Ifn{varepsilon}-/- mice and highly susceptible Ifnar1-/-mice against vaginal ZIKV infection, indicating that IFN{varepsilon} was sufficient to provide protection even in the absence of signals from other type I IFNs and in an IFNAR1-independent manner. Our findings reveal a potentially critical role for IFN{varepsilon} in mediating protection against transmission of ZIKV in the context of sexual contact. SignificanceInterferon {varepsilon} (IFN{varepsilon}), a unique Type I IFN that is highly expressed in the epithelium of the female reproductive tract (FRT), is thought to protect the host against sexually transmitted infections (STIs) but the mechanism of action is not defined. Zika virus (ZIKV), a causative agent for preterm birth and other severe diseases in pregnant women, can be spread through vaginal transmission. Here, we show that mice lacking the Ifn{varepsilon} gene have abnormal epithelial development and tissue architecture in the cervicovaginal tract. The role of IFN{varepsilon} in protecting host against ZIKV is FRT-specific and is independent of IFNAR1 signaling. Our findings suggest potential preventive strategies based on harnessing mucosal immunity against STIs.

immunology↗